Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2014-10-30

FDA Approved: HYDROCORTISONE BUTYRATE — Supplemental Application (Oceanside Pharmaceuticals)

View source ↗

Summary

FDA approved a supplemental application for hydrocortisone butyrate from Oceanside Pharmaceuticals, resulting in changes to the product label.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydrocortisone Butyrate (hydrocortisone butyrate)

Snippet

SUPPL AP for HYDROCORTISONE BUTYRATE (HYDROCORTISONE BUTYRATE)